NEWSROOM
Here you will find the ad hoc announcements and corporate news of Darwin AG for viewing and downloading as a PDF file.
2025
Stock Split in Ratio 1:3 Resolved
Turnover 2024 Outlook 2025
2024
AD-HOC Announcement Acquisition MEDICOPHARM
Acquisition MEDICOPHARM
Darwin AG publishes issuer report for the first half of 2024
Darwin AG: Subsidiary 305 Care starts with successful market launch
AD-HOC-NOTIFICATION: Darwin Group signs supply agreement for genetic tests and nutritional supplements with Cardone Ventures LLC
2023
CORPORATE NEWS: Darwin AG included in the m:access segment of the Munich Stock Exchange and
XETRA listing
CORPORATE NEWS: Darwin AG participates in funding round at GenePlanet – access to growth markets in Eastern Europe
AD-HOC-NOTIFICATION: Darwin AG acquires majority of the shares in INOPHA GmbH and ChiruTec GmbH. (german)
2021
AD-HOC-NOTIFICATION: Novogenia Holding AG is aware of sales estimates for 2021 due to the ongoing testing requirements in the context of the corona pandemic (german)
CORPORATE NEWS: Core competencies and business areas
AD-HOC-NOTIFICATION: Board member Markus Wenner is stepping down from his mandate as planned
GENOPEDIA
Browse through our online encyclopedia for genetics and see what our Deep Genome AI engine has gathered from millions of scientific publications as a basis of automated genome analysis.
